nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CB—lung cancer	0.147	0.312	CbGaD
Caffeine—PIK3CD—lung cancer	0.147	0.312	CbGaD
Caffeine—PIK3CA—lung cancer	0.114	0.241	CbGaD
Caffeine—CYP2E1—lung cancer	0.0253	0.0537	CbGaD
Caffeine—CYP1A1—lung cancer	0.0249	0.053	CbGaD
Caffeine—CYP1B1—Erlotinib—lung cancer	0.0199	0.0671	CbGbCtD
Caffeine—CYP1B1—Paclitaxel—lung cancer	0.0182	0.0614	CbGbCtD
Caffeine—CYP1A1—Gefitinib—lung cancer	0.0148	0.0498	CbGbCtD
Caffeine—ABCB1—lung cancer	0.0133	0.0282	CbGaD
Caffeine—CYP1B1—Docetaxel—lung cancer	0.0132	0.0444	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—lung cancer	0.00981	0.0331	CbGbCtD
Caffeine—CYP3A5—Gefitinib—lung cancer	0.00886	0.0299	CbGbCtD
Caffeine—CYP1A1—Erlotinib—lung cancer	0.00872	0.0294	CbGbCtD
Caffeine—CYP3A5—Teniposide—lung cancer	0.00859	0.029	CbGbCtD
Caffeine—CYP3A7—Paclitaxel—lung cancer	0.00639	0.0216	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00639	0.0216	CbGbCtD
Caffeine—CYP3A7—Irinotecan—lung cancer	0.0063	0.0213	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0063	0.0213	CbGbCtD
Caffeine—ABCB1—Topotecan—lung cancer	0.0063	0.0213	CbGbCtD
Caffeine—CYP2C9—Gefitinib—lung cancer	0.00594	0.02	CbGbCtD
Caffeine—ABCB1—Gefitinib—lung cancer	0.00576	0.0195	CbGbCtD
Caffeine—CYP2C9—Teniposide—lung cancer	0.00576	0.0194	CbGbCtD
Caffeine—CYP2D6—Gefitinib—lung cancer	0.00543	0.0183	CbGbCtD
Caffeine—CYP3A5—Crizotinib—lung cancer	0.00543	0.0183	CbGbCtD
Caffeine—CYP3A5—Erlotinib—lung cancer	0.00524	0.0177	CbGbCtD
Caffeine—CYP2C8—Erlotinib—lung cancer	0.00503	0.017	CbGbCtD
Caffeine—CYP2E1—Etoposide—lung cancer	0.00487	0.0165	CbGbCtD
Caffeine—CYP3A5—Paclitaxel—lung cancer	0.00479	0.0162	CbGbCtD
Caffeine—CYP3A5—Irinotecan—lung cancer	0.00473	0.016	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00462	0.0156	CbGbCtD
Caffeine—CYP3A7—Docetaxel—lung cancer	0.00462	0.0156	CbGbCtD
Caffeine—CYP2C8—Paclitaxel—lung cancer	0.00461	0.0156	CbGbCtD
Caffeine—ABCB1—Vinorelbine—lung cancer	0.00444	0.015	CbGbCtD
Caffeine—CYP2D6—Vinorelbine—lung cancer	0.00418	0.0141	CbGbCtD
Caffeine—CYP1A2—Erlotinib—lung cancer	0.0039	0.0132	CbGbCtD
Caffeine—CYP3A5—Etoposide—lung cancer	0.00379	0.0128	CbGbCtD
Caffeine—CYP3A4—Topotecan—lung cancer	0.00378	0.0127	CbGbCtD
Caffeine—CYP2C8—Etoposide—lung cancer	0.00364	0.0123	CbGbCtD
Caffeine—ABCB1—Crizotinib—lung cancer	0.00353	0.0119	CbGbCtD
Caffeine—CYP3A5—Docetaxel—lung cancer	0.00347	0.0117	CbGbCtD
Caffeine—CYP3A4—Gefitinib—lung cancer	0.00345	0.0117	CbGbCtD
Caffeine—ABCB1—Gemcitabine—lung cancer	0.00345	0.0117	CbGbCtD
Caffeine—ABCB1—Erlotinib—lung cancer	0.00341	0.0115	CbGbCtD
Caffeine—CYP3A4—Teniposide—lung cancer	0.00335	0.0113	CbGbCtD
Caffeine—CYP2C9—Paclitaxel—lung cancer	0.00321	0.0108	CbGbCtD
Caffeine—CYP2D6—Erlotinib—lung cancer	0.00321	0.0108	CbGbCtD
Caffeine—ABCB1—Paclitaxel—lung cancer	0.00312	0.0105	CbGbCtD
Caffeine—ABCB1—Irinotecan—lung cancer	0.00308	0.0104	CbGbCtD
Caffeine—CYP1A2—Etoposide—lung cancer	0.00282	0.00951	CbGbCtD
Caffeine—ABCB1—Vinblastine—lung cancer	0.00274	0.00924	CbGbCtD
Caffeine—CYP3A4—Vinorelbine—lung cancer	0.00266	0.00898	CbGbCtD
Caffeine—CYP2C9—Cisplatin—lung cancer	0.00258	0.00873	CbGbCtD
Caffeine—CYP2D6—Vinblastine—lung cancer	0.00258	0.0087	CbGbCtD
Caffeine—ABCB1—Cisplatin—lung cancer	0.00251	0.00847	CbGbCtD
Caffeine—ABCB1—Etoposide—lung cancer	0.00246	0.00832	CbGbCtD
Caffeine—ABCB1—Docetaxel—lung cancer	0.00226	0.00761	CbGbCtD
Caffeine—CYP3A4—Crizotinib—lung cancer	0.00212	0.00714	CbGbCtD
Caffeine—ATM—mammary gland—lung cancer	0.00205	0.0478	CbGeAlD
Caffeine—CYP3A4—Erlotinib—lung cancer	0.00204	0.00689	CbGbCtD
Caffeine—PIK3CB—Irinotecan—Topotecan—lung cancer	0.00196	0.837	CbGdCrCtD
Caffeine—PRKDC—mammary gland—lung cancer	0.00194	0.0452	CbGeAlD
Caffeine—CYP3A4—Paclitaxel—lung cancer	0.00187	0.00631	CbGbCtD
Caffeine—CYP3A4—Irinotecan—lung cancer	0.00184	0.00622	CbGbCtD
Caffeine—PIK3CD—mammary gland—lung cancer	0.00182	0.0424	CbGeAlD
Caffeine—ABCB1—Doxorubicin—lung cancer	0.00168	0.00567	CbGbCtD
Caffeine—CYP3A4—Vinblastine—lung cancer	0.00164	0.00553	CbGbCtD
Caffeine—ABCB1—Methotrexate—lung cancer	0.00163	0.0055	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—lung cancer	0.00158	0.00535	CbGbCtD
Caffeine—PIK3CA—mammary gland—lung cancer	0.00157	0.0366	CbGeAlD
Caffeine—CYP3A4—Etoposide—lung cancer	0.00148	0.00498	CbGbCtD
Caffeine—ATM—respiratory system—lung cancer	0.00136	0.0319	CbGeAlD
Caffeine—CYP3A4—Docetaxel—lung cancer	0.00135	0.00456	CbGbCtD
Caffeine—PIK3CD—respiratory system—lung cancer	0.00121	0.0283	CbGeAlD
Caffeine—ATM—epithelium—lung cancer	0.00114	0.0266	CbGeAlD
Caffeine—PRKDC—bronchus—lung cancer	0.00106	0.0248	CbGeAlD
Caffeine—PIK3CB—respiratory system—lung cancer	0.00106	0.0246	CbGeAlD
Caffeine—PIK3CA—respiratory system—lung cancer	0.00104	0.0244	CbGeAlD
Caffeine—PIK3CD—epithelium—lung cancer	0.00101	0.0236	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—lung cancer	0.00101	0.0034	CbGbCtD
Caffeine—PIK3CD—bronchus—lung cancer	0.000996	0.0233	CbGeAlD
Caffeine—PRKDC—trachea—lung cancer	0.000954	0.0223	CbGeAlD
Caffeine—ATM—cardiac atrium—lung cancer	0.000947	0.0221	CbGeAlD
Caffeine—PRKDC—cardiac atrium—lung cancer	0.000896	0.0209	CbGeAlD
Caffeine—PIK3CB—epithelium—lung cancer	0.000882	0.0206	CbGeAlD
Caffeine—PIK3CA—epithelium—lung cancer	0.000873	0.0204	CbGeAlD
Caffeine—PIK3CB—bronchus—lung cancer	0.000869	0.0203	CbGeAlD
Caffeine—PIK3CA—bronchus—lung cancer	0.00086	0.0201	CbGeAlD
Caffeine—ATM—bone marrow—lung cancer	0.0008	0.0187	CbGeAlD
Caffeine—PIK3CB—trachea—lung cancer	0.00078	0.0182	CbGeAlD
Caffeine—PRKDC—bone marrow—lung cancer	0.000756	0.0177	CbGeAlD
Caffeine—PIK3CB—cardiac atrium—lung cancer	0.000733	0.0171	CbGeAlD
Caffeine—PIK3CA—cardiac atrium—lung cancer	0.000725	0.0169	CbGeAlD
Caffeine—ATM—lung—lung cancer	0.000725	0.0169	CbGeAlD
Caffeine—PIK3CD—bone marrow—lung cancer	0.000709	0.0166	CbGeAlD
Caffeine—PRKDC—lung—lung cancer	0.000685	0.016	CbGeAlD
Caffeine—PIK3CD—lung—lung cancer	0.000643	0.015	CbGeAlD
Caffeine—ADORA2B—bronchus—lung cancer	0.000633	0.0148	CbGeAlD
Caffeine—PIK3CB—bone marrow—lung cancer	0.000619	0.0144	CbGeAlD
Caffeine—PIK3CA—bone marrow—lung cancer	0.000612	0.0143	CbGeAlD
Caffeine—ADORA2B—trachea—lung cancer	0.000568	0.0133	CbGeAlD
Caffeine—PIK3CB—lung—lung cancer	0.00056	0.0131	CbGeAlD
Caffeine—PIK3CA—lung—lung cancer	0.000555	0.013	CbGeAlD
Caffeine—CYP1B1—mammary gland—lung cancer	0.000525	0.0123	CbGeAlD
Caffeine—ATM—lymph node—lung cancer	0.000496	0.0116	CbGeAlD
Caffeine—PRKDC—lymph node—lung cancer	0.000469	0.0109	CbGeAlD
Caffeine—PIK3CD—lymph node—lung cancer	0.000439	0.0103	CbGeAlD
Caffeine—PDE4B—respiratory system—lung cancer	0.000408	0.00954	CbGeAlD
Caffeine—ADORA2B—lung—lung cancer	0.000408	0.00953	CbGeAlD
Caffeine—CYP2C8—mammary gland—lung cancer	0.000402	0.00939	CbGeAlD
Caffeine—PIK3CB—lymph node—lung cancer	0.000383	0.00895	CbGeAlD
Caffeine—ADORA1—cardiac atrium—lung cancer	0.000383	0.00895	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vinorelbine—lung cancer	0.000383	0.163	CbGdCrCtD
Caffeine—PIK3CA—lymph node—lung cancer	0.000379	0.00886	CbGeAlD
Caffeine—Theobromine—CYP2E1—lung cancer	0.000361	0.49	CrCbGaD
Caffeine—CYP2C9—mammary gland—lung cancer	0.000357	0.00834	CbGeAlD
Caffeine—CYP1B1—respiratory system—lung cancer	0.00035	0.00817	CbGeAlD
Caffeine—PDE4B—bronchus—lung cancer	0.000336	0.00785	CbGeAlD
Caffeine—PDE4B—trachea—lung cancer	0.000302	0.00705	CbGeAlD
Caffeine—ADORA1—lung—lung cancer	0.000293	0.00685	CbGeAlD
Caffeine—PDE4B—cardiac atrium—lung cancer	0.000284	0.00662	CbGeAlD
Caffeine—Sepsis—Irinotecan—lung cancer	0.000253	0.00371	CcSEcCtD
Caffeine—Pulmonary oedema—Gemcitabine—lung cancer	0.000253	0.00371	CcSEcCtD
Caffeine—CYP1A2—respiratory system—lung cancer	0.000251	0.00586	CbGeAlD
Caffeine—CYP1A1—respiratory system—lung cancer	0.000247	0.00578	CbGeAlD
Caffeine—Sepsis—Gemcitabine—lung cancer	0.000246	0.00362	CcSEcCtD
Caffeine—Infection—Pemetrexed—lung cancer	0.000244	0.00358	CcSEcCtD
Caffeine—Infection—Gefitinib—lung cancer	0.000242	0.00356	CcSEcCtD
Caffeine—CYP3A5—respiratory system—lung cancer	0.000242	0.00565	CbGeAlD
Caffeine—Nervous system disorder—Pemetrexed—lung cancer	0.000241	0.00354	CcSEcCtD
Caffeine—Blood creatinine increased—Vinorelbine—lung cancer	0.00024	0.00353	CcSEcCtD
Caffeine—Dyspnoea—Crizotinib—lung cancer	0.000239	0.00352	CcSEcCtD
Caffeine—PDE4B—bone marrow—lung cancer	0.000239	0.00559	CbGeAlD
Caffeine—Nervous system disorder—Gefitinib—lung cancer	0.000239	0.00351	CcSEcCtD
Caffeine—Skin disorder—Pemetrexed—lung cancer	0.000238	0.0035	CcSEcCtD
Caffeine—Skin disorder—Gefitinib—lung cancer	0.000237	0.00348	CcSEcCtD
Caffeine—Gastrointestinal disorder—Crizotinib—lung cancer	0.000232	0.00341	CcSEcCtD
Caffeine—Infestation—Topotecan—lung cancer	0.000231	0.00339	CcSEcCtD
Caffeine—Infestation NOS—Topotecan—lung cancer	0.000231	0.00339	CcSEcCtD
Caffeine—Deafness—Gemcitabine—lung cancer	0.00023	0.00338	CcSEcCtD
Caffeine—Injury—Irinotecan—lung cancer	0.00023	0.00338	CcSEcCtD
Caffeine—Infestation NOS—Erlotinib—lung cancer	0.000229	0.00336	CcSEcCtD
Caffeine—Infestation—Erlotinib—lung cancer	0.000229	0.00336	CcSEcCtD
Caffeine—CYP2E1—respiratory system—lung cancer	0.000226	0.00527	CbGeAlD
Caffeine—Renal failure—Erlotinib—lung cancer	0.000225	0.0033	CcSEcCtD
Caffeine—Agitation—Teniposide—lung cancer	0.000224	0.00329	CcSEcCtD
Caffeine—Dyspnoea—Pemetrexed—lung cancer	0.000219	0.00321	CcSEcCtD
Caffeine—Dyspnoea—Gefitinib—lung cancer	0.000217	0.00319	CcSEcCtD
Caffeine—PDE4B—lung—lung cancer	0.000217	0.00506	CbGeAlD
Caffeine—Urine output increased—Paclitaxel—lung cancer	0.000215	0.00316	CcSEcCtD
Caffeine—Deafness—Cisplatin—lung cancer	0.000215	0.00315	CcSEcCtD
Caffeine—Haemoglobin—Vinblastine—lung cancer	0.000215	0.00315	CcSEcCtD
Caffeine—Haemorrhage—Vinblastine—lung cancer	0.000214	0.00314	CcSEcCtD
Caffeine—Gastrointestinal disorder—Pemetrexed—lung cancer	0.000212	0.00311	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Irinotecan—lung cancer	0.000212	0.00311	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gefitinib—lung cancer	0.000211	0.00309	CcSEcCtD
Caffeine—Sepsis—Etoposide—lung cancer	0.00021	0.00309	CcSEcCtD
Caffeine—Hypertension—Teniposide—lung cancer	0.00021	0.00309	CcSEcCtD
Caffeine—Haemoglobin—Topotecan—lung cancer	0.000208	0.00306	CcSEcCtD
Caffeine—Haemorrhage—Topotecan—lung cancer	0.000207	0.00305	CcSEcCtD
Caffeine—CYP1A1—epithelium—lung cancer	0.000207	0.00483	CbGeAlD
Caffeine—Haemoglobin—Erlotinib—lung cancer	0.000206	0.00303	CcSEcCtD
Caffeine—Sepsis—Paclitaxel—lung cancer	0.000206	0.00303	CcSEcCtD
Caffeine—Haemorrhage—Erlotinib—lung cancer	0.000205	0.00301	CcSEcCtD
Caffeine—CYP1A1—bronchus—lung cancer	0.000204	0.00476	CbGeAlD
Caffeine—ADORA1—lymph node—lung cancer	0.000201	0.00468	CbGeAlD
Caffeine—Blood creatinine increased—Irinotecan—lung cancer	0.000198	0.00291	CcSEcCtD
Caffeine—Infestation NOS—Vinorelbine—lung cancer	0.000198	0.0029	CcSEcCtD
Caffeine—Infestation—Vinorelbine—lung cancer	0.000198	0.0029	CcSEcCtD
Caffeine—Infection—Teniposide—lung cancer	0.000198	0.0029	CcSEcCtD
Caffeine—Tachycardia—Teniposide—lung cancer	0.000194	0.00285	CcSEcCtD
Caffeine—Blood creatinine increased—Gemcitabine—lung cancer	0.000193	0.00284	CcSEcCtD
Caffeine—Deafness—Paclitaxel—lung cancer	0.000193	0.00283	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—lung cancer	0.000192	0.00282	CcSEcCtD
Caffeine—Theophylline—CYP2E1—lung cancer	0.000189	0.257	CrCbGaD
Caffeine—Injury—Paclitaxel—lung cancer	0.000188	0.00276	CcSEcCtD
Caffeine—Immune system disorder—Topotecan—lung cancer	0.000187	0.00275	CcSEcCtD
Caffeine—Theophylline—CYP1A1—lung cancer	0.000186	0.253	CrCbGaD
Caffeine—CYP1B1—lung—lung cancer	0.000186	0.00434	CbGeAlD
Caffeine—Irritability—Cisplatin—lung cancer	0.000183	0.00269	CcSEcCtD
Caffeine—CYP1A1—trachea—lung cancer	0.000183	0.00427	CbGeAlD
Caffeine—Hypercalcaemia—Doxorubicin—lung cancer	0.000181	0.00266	CcSEcCtD
Caffeine—Hypersensitivity—Pemetrexed—lung cancer	0.000181	0.00266	CcSEcCtD
Caffeine—Malnutrition—Topotecan—lung cancer	0.000181	0.00265	CcSEcCtD
Caffeine—Blood creatinine increased—Cisplatin—lung cancer	0.00018	0.00264	CcSEcCtD
Caffeine—Hypersensitivity—Gefitinib—lung cancer	0.00018	0.00264	CcSEcCtD
Caffeine—Pulmonary oedema—Docetaxel—lung cancer	0.000179	0.00263	CcSEcCtD
Caffeine—Malnutrition—Erlotinib—lung cancer	0.000179	0.00262	CcSEcCtD
Caffeine—Dyspnoea—Teniposide—lung cancer	0.000177	0.0026	CcSEcCtD
Caffeine—Hypoglycaemia—Paclitaxel—lung cancer	0.000177	0.0026	CcSEcCtD
Caffeine—Sepsis—Docetaxel—lung cancer	0.000175	0.00257	CcSEcCtD
Caffeine—CYP1A1—cardiac atrium—lung cancer	0.000172	0.00401	CbGeAlD
Caffeine—Rash—Crizotinib—lung cancer	0.000169	0.00249	CcSEcCtD
Caffeine—Dermatitis—Crizotinib—lung cancer	0.000169	0.00249	CcSEcCtD
Caffeine—Cardiac disorder—Vinorelbine—lung cancer	0.000165	0.00242	CcSEcCtD
Caffeine—Deafness—Docetaxel—lung cancer	0.000163	0.0024	CcSEcCtD
Caffeine—Blood creatinine increased—Paclitaxel—lung cancer	0.000162	0.00237	CcSEcCtD
Caffeine—Convulsion—Vinblastine—lung cancer	0.000161	0.00237	CcSEcCtD
Caffeine—Hyperglycaemia—Gemcitabine—lung cancer	0.000161	0.00236	CcSEcCtD
Caffeine—Hypertension—Vinblastine—lung cancer	0.00016	0.00236	CcSEcCtD
Caffeine—Immune system disorder—Vinorelbine—lung cancer	0.00016	0.00235	CcSEcCtD
Caffeine—Renal failure—Irinotecan—lung cancer	0.00016	0.00235	CcSEcCtD
Caffeine—Dry skin—Paclitaxel—lung cancer	0.000158	0.00232	CcSEcCtD
Caffeine—Renal failure—Gemcitabine—lung cancer	0.000156	0.00229	CcSEcCtD
Caffeine—Rash—Pemetrexed—lung cancer	0.000155	0.00227	CcSEcCtD
Caffeine—Dermatitis—Pemetrexed—lung cancer	0.000155	0.00227	CcSEcCtD
Caffeine—Malnutrition—Vinorelbine—lung cancer	0.000154	0.00227	CcSEcCtD
Caffeine—Rash—Gefitinib—lung cancer	0.000154	0.00226	CcSEcCtD
Caffeine—Dermatitis—Gefitinib—lung cancer	0.000154	0.00226	CcSEcCtD
Caffeine—PDE4B—lymph node—lung cancer	0.000148	0.00346	CbGeAlD
Caffeine—Haemoglobin—Irinotecan—lung cancer	0.000147	0.00216	CcSEcCtD
Caffeine—Hypersensitivity—Teniposide—lung cancer	0.000146	0.00215	CcSEcCtD
Caffeine—Infection—Topotecan—lung cancer	0.000146	0.00215	CcSEcCtD
Caffeine—Haemorrhage—Irinotecan—lung cancer	0.000146	0.00215	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—lung cancer	0.000146	0.00215	CcSEcCtD
Caffeine—Renal failure—Cisplatin—lung cancer	0.000145	0.00214	CcSEcCtD
Caffeine—Infection—Erlotinib—lung cancer	0.000145	0.00213	CcSEcCtD
Caffeine—Nervous system disorder—Topotecan—lung cancer	0.000145	0.00212	CcSEcCtD
Caffeine—Haemoglobin—Gemcitabine—lung cancer	0.000143	0.0021	CcSEcCtD
Caffeine—Skin disorder—Topotecan—lung cancer	0.000143	0.0021	CcSEcCtD
Caffeine—Nervous system disorder—Erlotinib—lung cancer	0.000143	0.0021	CcSEcCtD
Caffeine—Haemorrhage—Gemcitabine—lung cancer	0.000143	0.00209	CcSEcCtD
Caffeine—Skin disorder—Erlotinib—lung cancer	0.000142	0.00208	CcSEcCtD
Caffeine—Cardiac disorder—Irinotecan—lung cancer	0.000136	0.002	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—lung cancer	0.000136	0.00199	CcSEcCtD
Caffeine—Infestation—Etoposide—lung cancer	0.000136	0.00199	CcSEcCtD
Caffeine—Hyperglycaemia—Paclitaxel—lung cancer	0.000134	0.00198	CcSEcCtD
Caffeine—Dry skin—Docetaxel—lung cancer	0.000134	0.00197	CcSEcCtD
Caffeine—Hypertension—Vinorelbine—lung cancer	0.000133	0.00196	CcSEcCtD
Caffeine—Renal failure—Etoposide—lung cancer	0.000133	0.00196	CcSEcCtD
Caffeine—CYP1A2—lung—lung cancer	0.000133	0.00311	CbGeAlD
Caffeine—Infestation—Paclitaxel—lung cancer	0.000133	0.00195	CcSEcCtD
Caffeine—Infestation NOS—Paclitaxel—lung cancer	0.000133	0.00195	CcSEcCtD
Caffeine—Cardiac disorder—Gemcitabine—lung cancer	0.000132	0.00194	CcSEcCtD
Caffeine—Immune system disorder—Irinotecan—lung cancer	0.000132	0.00194	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—lung cancer	0.000132	0.00194	CcSEcCtD
Caffeine—CYP1A1—lung—lung cancer	0.000131	0.00307	CbGeAlD
Caffeine—Dyspnoea—Topotecan—lung cancer	0.000131	0.00193	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—lung cancer	0.000131	0.00193	CcSEcCtD
Caffeine—Renal failure—Paclitaxel—lung cancer	0.000131	0.00192	CcSEcCtD
Caffeine—Dyspnoea—Erlotinib—lung cancer	0.00013	0.00191	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—lung cancer	0.000129	0.0019	CcSEcCtD
Caffeine—Immune system disorder—Gemcitabine—lung cancer	0.000129	0.00189	CcSEcCtD
Caffeine—ABCB1—respiratory system—lung cancer	0.000129	0.003	CbGeAlD
Caffeine—CYP3A5—lung—lung cancer	0.000128	0.003	CbGeAlD
Caffeine—Gastrointestinal disorder—Topotecan—lung cancer	0.000127	0.00187	CcSEcCtD
Caffeine—CYP1B1—lymph node—lung cancer	0.000127	0.00297	CbGeAlD
Caffeine—Sepsis—Methotrexate—lung cancer	0.000126	0.00185	CcSEcCtD
Caffeine—Gastrointestinal disorder—Erlotinib—lung cancer	0.000126	0.00185	CcSEcCtD
Caffeine—Rash—Teniposide—lung cancer	0.000125	0.00184	CcSEcCtD
Caffeine—Dermatitis—Teniposide—lung cancer	0.000125	0.00184	CcSEcCtD
Caffeine—Infection—Vinorelbine—lung cancer	0.000125	0.00184	CcSEcCtD
Caffeine—Nervous system disorder—Vinorelbine—lung cancer	0.000124	0.00182	CcSEcCtD
Caffeine—Cardiac disorder—Cisplatin—lung cancer	0.000123	0.00181	CcSEcCtD
Caffeine—Tachycardia—Vinorelbine—lung cancer	0.000123	0.00181	CcSEcCtD
Caffeine—Skin disorder—Vinorelbine—lung cancer	0.000122	0.0018	CcSEcCtD
Caffeine—Immune system disorder—Cisplatin—lung cancer	0.00012	0.00176	CcSEcCtD
Caffeine—Haemoglobin—Paclitaxel—lung cancer	0.00012	0.00176	CcSEcCtD
Caffeine—CYP2E1—lung—lung cancer	0.00012	0.0028	CbGeAlD
Caffeine—Haemorrhage—Paclitaxel—lung cancer	0.000119	0.00175	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—lung cancer	0.000116	0.0017	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—lung cancer	0.000113	0.00166	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—lung cancer	0.000113	0.00166	CcSEcCtD
Caffeine—Infestation—Docetaxel—lung cancer	0.000113	0.00166	CcSEcCtD
Caffeine—Dyspnoea—Vinorelbine—lung cancer	0.000112	0.00165	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—lung cancer	0.000112	0.00164	CcSEcCtD
Caffeine—Hypersensitivity—Vinblastine—lung cancer	0.000112	0.00164	CcSEcCtD
Caffeine—Renal failure—Docetaxel—lung cancer	0.000111	0.00163	CcSEcCtD
Caffeine—Cardiac disorder—Paclitaxel—lung cancer	0.000111	0.00163	CcSEcCtD
Caffeine—Hypertension—Irinotecan—lung cancer	0.00011	0.00162	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—lung cancer	0.00011	0.00162	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—lung cancer	0.000109	0.0016	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000109	0.0016	CcSEcCtD
Caffeine—Hypersensitivity—Topotecan—lung cancer	0.000109	0.0016	CcSEcCtD
Caffeine—Immune system disorder—Paclitaxel—lung cancer	0.000108	0.00158	CcSEcCtD
Caffeine—ABCB1—epithelium—lung cancer	0.000107	0.00251	CbGeAlD
Caffeine—Hypertension—Gemcitabine—lung cancer	0.000107	0.00157	CcSEcCtD
Caffeine—Malnutrition—Paclitaxel—lung cancer	0.000104	0.00153	CcSEcCtD
Caffeine—Infection—Irinotecan—lung cancer	0.000103	0.00152	CcSEcCtD
Caffeine—Nervous system disorder—Irinotecan—lung cancer	0.000102	0.0015	CcSEcCtD
Caffeine—Haemoglobin—Docetaxel—lung cancer	0.000102	0.00149	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—lung cancer	0.000101	0.00149	CcSEcCtD
Caffeine—Nervousness—Paclitaxel—lung cancer	0.000101	0.00148	CcSEcCtD
Caffeine—Infection—Gemcitabine—lung cancer	0.000101	0.00148	CcSEcCtD
Caffeine—Irritability—Methotrexate—lung cancer	0.000101	0.00148	CcSEcCtD
Caffeine—Convulsion—Cisplatin—lung cancer	0.0001	0.00147	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—lung cancer	9.93e-05	0.00146	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—lung cancer	9.84e-05	0.00145	CcSEcCtD
Caffeine—Agitation—Paclitaxel—lung cancer	9.55e-05	0.0014	CcSEcCtD
Caffeine—ABCB1—trachea—lung cancer	9.5e-05	0.00222	CbGeAlD
Caffeine—Cardiac disorder—Docetaxel—lung cancer	9.39e-05	0.00138	CcSEcCtD
Caffeine—Infection—Cisplatin—lung cancer	9.38e-05	0.00138	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—lung cancer	9.35e-05	0.00137	CcSEcCtD
Caffeine—Rash—Topotecan—lung cancer	9.29e-05	0.00137	CcSEcCtD
Caffeine—Hypersensitivity—Vinorelbine—lung cancer	9.29e-05	0.00136	CcSEcCtD
Caffeine—Dermatitis—Topotecan—lung cancer	9.28e-05	0.00136	CcSEcCtD
Caffeine—Dyspnoea—Irinotecan—lung cancer	9.27e-05	0.00136	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—lung cancer	9.26e-05	0.00136	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—lung cancer	9.21e-05	0.00135	CcSEcCtD
Caffeine—Rash—Erlotinib—lung cancer	9.19e-05	0.00135	CcSEcCtD
Caffeine—Dermatitis—Erlotinib—lung cancer	9.18e-05	0.00135	CcSEcCtD
Caffeine—Convulsion—Etoposide—lung cancer	9.18e-05	0.00135	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—lung cancer	9.17e-05	0.00135	CcSEcCtD
Caffeine—Hypertension—Etoposide—lung cancer	9.15e-05	0.00134	CcSEcCtD
Caffeine—Immune system disorder—Docetaxel—lung cancer	9.14e-05	0.00134	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	9.13e-05	0.00134	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—lung cancer	9.03e-05	0.00133	CcSEcCtD
Caffeine—Convulsion—Paclitaxel—lung cancer	9e-05	0.00132	CcSEcCtD
Caffeine—CYP1A1—lymph node—lung cancer	8.99e-05	0.0021	CbGeAlD
Caffeine—Gastrointestinal disorder—Irinotecan—lung cancer	8.98e-05	0.00132	CcSEcCtD
Caffeine—Hypertension—Paclitaxel—lung cancer	8.97e-05	0.00132	CcSEcCtD
Caffeine—Malnutrition—Docetaxel—lung cancer	8.81e-05	0.00129	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gemcitabine—lung cancer	8.74e-05	0.00128	CcSEcCtD
Caffeine—Infection—Etoposide—lung cancer	8.59e-05	0.00126	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—lung cancer	8.55e-05	0.00126	CcSEcCtD
Caffeine—Tachycardia—Etoposide—lung cancer	8.44e-05	0.00124	CcSEcCtD
Caffeine—Infection—Paclitaxel—lung cancer	8.42e-05	0.00124	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—lung cancer	8.42e-05	0.00124	CcSEcCtD
Caffeine—Skin disorder—Etoposide—lung cancer	8.4e-05	0.00123	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—lung cancer	8.36e-05	0.00123	CcSEcCtD
Caffeine—Nervous system disorder—Paclitaxel—lung cancer	8.31e-05	0.00122	CcSEcCtD
Caffeine—Tachycardia—Paclitaxel—lung cancer	8.27e-05	0.00122	CcSEcCtD
Caffeine—Skin disorder—Paclitaxel—lung cancer	8.24e-05	0.00121	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cisplatin—lung cancer	8.15e-05	0.0012	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—lung cancer	8.12e-05	0.00119	CcSEcCtD
Caffeine—Infestation—Methotrexate—lung cancer	8.12e-05	0.00119	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—lung cancer	8.08e-05	0.00119	CcSEcCtD
Caffeine—Renal failure—Methotrexate—lung cancer	7.98e-05	0.00117	CcSEcCtD
Caffeine—Rash—Vinorelbine—lung cancer	7.95e-05	0.00117	CcSEcCtD
Caffeine—Dermatitis—Vinorelbine—lung cancer	7.94e-05	0.00117	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—lung cancer	7.71e-05	0.00113	CcSEcCtD
Caffeine—Hypersensitivity—Irinotecan—lung cancer	7.66e-05	0.00113	CcSEcCtD
Caffeine—Convulsion—Docetaxel—lung cancer	7.63e-05	0.00112	CcSEcCtD
Caffeine—Hypertension—Docetaxel—lung cancer	7.6e-05	0.00112	CcSEcCtD
Caffeine—Dyspnoea—Paclitaxel—lung cancer	7.56e-05	0.00111	CcSEcCtD
Caffeine—ABCB1—bone marrow—lung cancer	7.53e-05	0.00176	CbGeAlD
Caffeine—Gastrointestinal disorder—Etoposide—lung cancer	7.47e-05	0.0011	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—lung cancer	7.33e-05	0.00108	CcSEcCtD
Caffeine—Gastrointestinal disorder—Paclitaxel—lung cancer	7.32e-05	0.00108	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—lung cancer	7.29e-05	0.00107	CcSEcCtD
Caffeine—Infection—Docetaxel—lung cancer	7.14e-05	0.00105	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—lung cancer	7.11e-05	0.00105	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—lung cancer	7.05e-05	0.00104	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—lung cancer	7.03e-05	0.00103	CcSEcCtD
Caffeine—Infestation—Doxorubicin—lung cancer	7.03e-05	0.00103	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—lung cancer	7.01e-05	0.00103	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—lung cancer	6.98e-05	0.00103	CcSEcCtD
Caffeine—Hypersensitivity—Cisplatin—lung cancer	6.95e-05	0.00102	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—lung cancer	6.91e-05	0.00102	CcSEcCtD
Caffeine—ABCB1—lung—lung cancer	6.83e-05	0.00159	CbGeAlD
Caffeine—Cardiac disorder—Methotrexate—lung cancer	6.77e-05	0.000994	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—lung cancer	6.59e-05	0.000967	CcSEcCtD
Caffeine—Rash—Irinotecan—lung cancer	6.55e-05	0.000963	CcSEcCtD
Caffeine—Dermatitis—Irinotecan—lung cancer	6.55e-05	0.000962	CcSEcCtD
Caffeine—Dyspnoea—Docetaxel—lung cancer	6.41e-05	0.000941	CcSEcCtD
Caffeine—Rash—Gemcitabine—lung cancer	6.39e-05	0.000938	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—lung cancer	6.38e-05	0.000937	CcSEcCtD
Caffeine—Hypersensitivity—Etoposide—lung cancer	6.37e-05	0.000936	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—lung cancer	6.35e-05	0.000932	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—lung cancer	6.34e-05	0.000932	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—lung cancer	6.31e-05	0.000927	CcSEcCtD
Caffeine—Hypersensitivity—Paclitaxel—lung cancer	6.25e-05	0.000918	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—lung cancer	6.2e-05	0.000912	CcSEcCtD
Caffeine—Rash—Cisplatin—lung cancer	5.95e-05	0.000874	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—lung cancer	5.95e-05	0.000874	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—lung cancer	5.86e-05	0.000861	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—lung cancer	5.7e-05	0.000838	CcSEcCtD
Caffeine—Convulsion—Methotrexate—lung cancer	5.5e-05	0.000808	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—lung cancer	5.5e-05	0.000807	CcSEcCtD
Caffeine—Rash—Etoposide—lung cancer	5.45e-05	0.000801	CcSEcCtD
Caffeine—Dermatitis—Etoposide—lung cancer	5.45e-05	0.0008	CcSEcCtD
Caffeine—Rash—Paclitaxel—lung cancer	5.35e-05	0.000785	CcSEcCtD
Caffeine—Dermatitis—Paclitaxel—lung cancer	5.34e-05	0.000785	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—lung cancer	5.34e-05	0.000784	CcSEcCtD
Caffeine—Hypersensitivity—Docetaxel—lung cancer	5.29e-05	0.000778	CcSEcCtD
Caffeine—Infection—Methotrexate—lung cancer	5.15e-05	0.000756	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—lung cancer	5.08e-05	0.000746	CcSEcCtD
Caffeine—Agitation—Doxorubicin—lung cancer	5.05e-05	0.000742	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—lung cancer	5.03e-05	0.000739	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—lung cancer	4.76e-05	0.0007	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—lung cancer	4.74e-05	0.000697	CcSEcCtD
Caffeine—ABCB1—lymph node—lung cancer	4.67e-05	0.00109	CbGeAlD
Caffeine—Dyspnoea—Methotrexate—lung cancer	4.62e-05	0.000678	CcSEcCtD
Caffeine—Rash—Docetaxel—lung cancer	4.53e-05	0.000666	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—lung cancer	4.53e-05	0.000665	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—lung cancer	4.47e-05	0.000657	CcSEcCtD
Caffeine—Infection—Doxorubicin—lung cancer	4.46e-05	0.000655	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—lung cancer	4.4e-05	0.000646	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—lung cancer	4.38e-05	0.000643	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—lung cancer	4.36e-05	0.00064	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—lung cancer	4e-05	0.000587	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—lung cancer	3.87e-05	0.000569	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—lung cancer	3.82e-05	0.000561	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—lung cancer	3.3e-05	0.000485	CcSEcCtD
Caffeine—Rash—Methotrexate—lung cancer	3.27e-05	0.00048	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—lung cancer	3.26e-05	0.000479	CcSEcCtD
Caffeine—Rash—Doxorubicin—lung cancer	2.83e-05	0.000415	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—lung cancer	2.83e-05	0.000415	CcSEcCtD
Caffeine—ADORA2A—Signaling Pathways—JUN—lung cancer	9.74e-07	8.16e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NQO1—lung cancer	9.71e-07	8.14e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAT—lung cancer	9.68e-07	8.12e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.62e-07	8.07e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.62e-07	8.07e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—lung cancer	9.57e-07	8.03e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CD—lung cancer	9.53e-07	7.99e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.5e-07	7.97e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—lung cancer	9.48e-07	7.95e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—lung cancer	9.47e-07	7.94e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—lung cancer	9.45e-07	7.92e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	9.44e-07	7.91e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.42e-07	7.9e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—lung cancer	9.42e-07	7.9e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—lung cancer	9.42e-07	7.9e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—lung cancer	9.41e-07	7.89e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—lung cancer	9.39e-07	7.87e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ERCC2—lung cancer	9.37e-07	7.86e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—STK11—lung cancer	9.37e-07	7.85e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—lung cancer	9.37e-07	7.85e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—lung cancer	9.36e-07	7.85e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO1—lung cancer	9.35e-07	7.84e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—UGT1A1—lung cancer	9.34e-07	7.83e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.32e-07	7.81e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—lung cancer	9.27e-07	7.78e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—lung cancer	9.25e-07	7.76e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TYMS—lung cancer	9.25e-07	7.75e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CB—lung cancer	9.21e-07	7.72e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.2e-07	7.71e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—lung cancer	9.19e-07	7.7e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTM1—lung cancer	9.14e-07	7.67e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—lung cancer	9.13e-07	7.65e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—lung cancer	9.04e-07	7.58e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNG11—lung cancer	9.01e-07	7.55e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EP300—lung cancer	8.98e-07	7.53e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—lung cancer	8.96e-07	7.51e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—STK11—lung cancer	8.83e-07	7.4e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—lung cancer	8.76e-07	7.35e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—STK11—lung cancer	8.75e-07	7.34e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—lung cancer	8.73e-07	7.32e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—lung cancer	8.67e-07	7.27e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1A1—lung cancer	8.67e-07	7.27e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—lung cancer	8.6e-07	7.22e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—APOA1—lung cancer	8.6e-07	7.21e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—lung cancer	8.59e-07	7.21e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—APOA1—lung cancer	8.58e-07	7.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDOA—lung cancer	8.58e-07	7.19e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—lung cancer	8.51e-07	7.13e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—lung cancer	8.5e-07	7.13e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAT—lung cancer	8.43e-07	7.07e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—lung cancer	8.42e-07	7.06e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—lung cancer	8.4e-07	7.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2E1—lung cancer	8.39e-07	7.03e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—lung cancer	8.34e-07	7e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA3—lung cancer	8.32e-07	6.98e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—lung cancer	8.32e-07	6.98e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—lung cancer	8.31e-07	6.97e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NQO1—lung cancer	8.29e-07	6.96e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—lung cancer	8.27e-07	6.93e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—lung cancer	8.23e-07	6.9e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—lung cancer	8.23e-07	6.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.21e-07	6.89e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—lung cancer	8.17e-07	6.85e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.12e-07	6.81e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—APOA1—lung cancer	8.11e-07	6.8e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADCY1—lung cancer	8.1e-07	6.79e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCG2—lung cancer	8.1e-07	6.79e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—lung cancer	8.1e-07	6.79e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—lung cancer	8.06e-07	6.76e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.05e-07	6.75e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—lung cancer	8.05e-07	6.75e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—lung cancer	7.96e-07	6.68e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—lung cancer	7.96e-07	6.68e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—lung cancer	7.96e-07	6.67e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAT—lung cancer	7.95e-07	6.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGDS—lung cancer	7.94e-07	6.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—lung cancer	7.94e-07	6.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.89e-07	6.62e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAT—lung cancer	7.88e-07	6.61e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—lung cancer	7.87e-07	6.6e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—lung cancer	7.86e-07	6.59e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—lung cancer	7.85e-07	6.58e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—lung cancer	7.84e-07	6.57e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.83e-07	6.57e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—lung cancer	7.83e-07	6.56e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—lung cancer	7.79e-07	6.53e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.77e-07	6.51e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—lung cancer	7.73e-07	6.48e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—lung cancer	7.7e-07	6.46e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—lung cancer	7.66e-07	6.43e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—lung cancer	7.65e-07	6.42e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—lung cancer	7.62e-07	6.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.61e-07	6.38e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GCLC—lung cancer	7.61e-07	6.38e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—lung cancer	7.59e-07	6.37e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—lung cancer	7.59e-07	6.37e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1A1—lung cancer	7.55e-07	6.33e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—lung cancer	7.53e-07	6.31e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—lung cancer	7.53e-07	6.31e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—lung cancer	7.5e-07	6.29e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—lung cancer	7.49e-07	6.28e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—STK11—lung cancer	7.48e-07	6.27e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—POMC—lung cancer	7.47e-07	6.27e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—POMC—lung cancer	7.46e-07	6.25e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—lung cancer	7.45e-07	6.24e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—lung cancer	7.44e-07	6.24e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—APOA1—lung cancer	7.43e-07	6.23e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—lung cancer	7.4e-07	6.21e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CREBBP—lung cancer	7.28e-07	6.11e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CREBBP—lung cancer	7.27e-07	6.09e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—lung cancer	7.23e-07	6.06e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO1—lung cancer	7.22e-07	6.05e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—lung cancer	7.18e-07	6.02e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—lung cancer	7.13e-07	5.98e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.12e-07	5.97e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1A1—lung cancer	7.11e-07	5.97e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—lung cancer	7.06e-07	5.92e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1A1—lung cancer	7.05e-07	5.91e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—POMC—lung cancer	7.05e-07	5.91e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—lung cancer	7.03e-07	5.89e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.02e-07	5.89e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—lung cancer	6.99e-07	5.87e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—lung cancer	6.95e-07	5.82e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—lung cancer	6.92e-07	5.8e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—lung cancer	6.9e-07	5.79e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—lung cancer	6.89e-07	5.78e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CREBBP—lung cancer	6.86e-07	5.76e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—lung cancer	6.85e-07	5.74e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—lung cancer	6.81e-07	5.71e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—lung cancer	6.8e-07	5.7e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—lung cancer	6.79e-07	5.69e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAT—lung cancer	6.73e-07	5.65e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.69e-07	5.61e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	6.64e-07	5.57e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—lung cancer	6.57e-07	5.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—lung cancer	6.55e-07	5.49e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—lung cancer	6.51e-07	5.46e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—APOA1—lung cancer	6.48e-07	5.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.47e-07	5.43e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—POMC—lung cancer	6.46e-07	5.42e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—lung cancer	6.43e-07	5.39e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—lung cancer	6.43e-07	5.39e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—lung cancer	6.42e-07	5.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NQO1—lung cancer	6.4e-07	5.37e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—lung cancer	6.36e-07	5.33e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CREBBP—lung cancer	6.29e-07	5.28e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—lung cancer	6.15e-07	5.15e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—APOA1—lung cancer	6.1e-07	5.12e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—APOA1—lung cancer	6.05e-07	5.07e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1A1—lung cancer	6.03e-07	5.05e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—lung cancer	6.02e-07	5.05e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—lung cancer	6e-07	5.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—lung cancer	5.98e-07	5.01e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—lung cancer	5.97e-07	5e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—lung cancer	5.96e-07	5e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—lung cancer	5.95e-07	4.99e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—lung cancer	5.91e-07	4.96e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—lung cancer	5.89e-07	4.94e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—lung cancer	5.88e-07	4.93e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.79e-07	4.86e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—STK11—lung cancer	5.77e-07	4.84e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—lung cancer	5.67e-07	4.76e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—POMC—lung cancer	5.63e-07	4.72e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—lung cancer	5.62e-07	4.71e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—lung cancer	5.62e-07	4.71e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—lung cancer	5.57e-07	4.67e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.52e-07	4.63e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CREBBP—lung cancer	5.48e-07	4.6e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—lung cancer	5.43e-07	4.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—lung cancer	5.34e-07	4.48e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—POMC—lung cancer	5.3e-07	4.45e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—POMC—lung cancer	5.26e-07	4.41e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—lung cancer	5.2e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—lung cancer	5.2e-07	4.36e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—lung cancer	5.2e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAT—lung cancer	5.2e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—lung cancer	5.19e-07	4.35e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—APOA1—lung cancer	5.17e-07	4.34e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CREBBP—lung cancer	5.17e-07	4.33e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—lung cancer	5.15e-07	4.32e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—lung cancer	5.13e-07	4.3e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CREBBP—lung cancer	5.12e-07	4.29e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—lung cancer	5.06e-07	4.25e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—lung cancer	5.05e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—lung cancer	4.96e-07	4.16e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—lung cancer	4.96e-07	4.16e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.95e-07	4.15e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—lung cancer	4.95e-07	4.15e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—lung cancer	4.91e-07	4.11e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—lung cancer	4.9e-07	4.11e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.9e-07	4.11e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—lung cancer	4.86e-07	4.07e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—lung cancer	4.84e-07	4.06e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—lung cancer	4.79e-07	4.02e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—lung cancer	4.72e-07	3.96e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—lung cancer	4.67e-07	3.92e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.65e-07	3.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—lung cancer	4.61e-07	3.87e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—lung cancer	4.59e-07	3.85e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—lung cancer	4.53e-07	3.8e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—lung cancer	4.49e-07	3.77e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—POMC—lung cancer	4.49e-07	3.77e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—lung cancer	4.49e-07	3.76e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CREBBP—lung cancer	4.38e-07	3.67e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—lung cancer	4.29e-07	3.59e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.27e-07	3.58e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.23e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—lung cancer	4.23e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—lung cancer	4.19e-07	3.52e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—lung cancer	4.15e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—lung cancer	4.14e-07	3.47e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—lung cancer	4.1e-07	3.44e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—APOA1—lung cancer	3.99e-07	3.35e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—lung cancer	3.92e-07	3.28e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—lung cancer	3.73e-07	3.13e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—lung cancer	3.69e-07	3.09e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—lung cancer	3.67e-07	3.08e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—lung cancer	3.66e-07	3.07e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—lung cancer	3.66e-07	3.07e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.64e-07	3.05e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—lung cancer	3.62e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—lung cancer	3.58e-07	3.01e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—lung cancer	3.52e-07	2.95e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—lung cancer	3.49e-07	2.93e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—POMC—lung cancer	3.47e-07	2.91e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—lung cancer	3.46e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CREBBP—lung cancer	3.38e-07	2.83e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.2e-07	2.69e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—lung cancer	3.17e-07	2.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—lung cancer	3.16e-07	2.65e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—lung cancer	3.13e-07	2.62e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—lung cancer	3e-07	2.51e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—lung cancer	2.99e-07	2.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—lung cancer	2.98e-07	2.5e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—lung cancer	2.83e-07	2.37e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.79e-07	2.34e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—lung cancer	2.77e-07	2.32e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—lung cancer	2.76e-07	2.32e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.6e-07	2.18e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—lung cancer	2.59e-07	2.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.58e-07	2.16e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—lung cancer	2.41e-07	2.02e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—lung cancer	2.3e-07	1.93e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—lung cancer	2.26e-07	1.89e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—lung cancer	2.21e-07	1.85e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—lung cancer	2.13e-07	1.78e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—lung cancer	2.11e-07	1.77e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—lung cancer	1.8e-07	1.51e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.7e-07	1.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—lung cancer	1.39e-07	1.17e-06	CbGpPWpGaD
